Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014 Journal Article


Authors: Appelbaum, F. R.; Anasetti, C.; Antin, J. H.; Atkins, H.; Davies, S.; Devine, S.; Giralt, S.; Heslop, H.; Laport, G.; Lee, S. J.; Logan, B.; Pasquini, M.; Pulsipher, M.; Stadtmauer, E.; Wingard, J. R.; Horowitz, M. M.
Article Title: Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2014
Keywords: leukemia; acute granulocytic leukemia; lenalidomide; prednisone; doxorubicin; placebo; rituximab; low drug dose; quality of life; bortezomib; lung toxicity; mantle cell lymphoma; multiple myeloma; dendritic cell; etoposide; cyclophosphamide; steroid; vincristine; hematopoietic stem cell transplantation; acute lymphoblastic leukemia; plasma cell; cancer regression; acute graft versus host disease; chronic graft versus host disease; cord blood stem cell transplantation; myelodysplastic syndrome; celecoxib; lymphoma; comorbidity; etanercept; gene therapy; allogeneic hematopoietic stem cell transplantation; large cell lymphoma; bone marrow transplantation; multiple sclerosis; cytomegalovirus infection; adoptive immunotherapy; autologous hematopoietic stem cell transplantation; azacitidine; myeloma; zoledronic acid; aplastic anemia; leukemia remission; hematopoietic cell transplantation; randomized controlled trial (topic); clinical trial (topic); study design; phase 2 clinical trial (topic); phase 3 clinical trial (topic); inborn error of metabolism; symposium; sickle cell anemia; hla dpb1 antigen; consolidation chemotherapy; quizartinib; ibrutinib; human; article; ixazomib
Journal Title: Biology of Blood and Marrow Transplantation
Volume: 21
Issue: 2
ISSN: 1083-8791
Publisher: Elsevier Inc.  
Date Published: 2015-02-01
Start Page: 202
End Page: 224
Language: English
DOI: 10.1016/j.bbmt.2014.10.003
PROVIDER: scopus
PUBMED: 25445636
PMCID: PMC4426907
DOI/URL:
Notes: Export Date: 2 February 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1050 Giralt